EN DE
Watch Kingfa Science & Technology (India) Limited for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Kingfa Science & Technology (India) Limited (KINGFA) fair value: what the stock is really worth

As of Nov 16, 2026: fair value (intrinsic value) of Kingfa Science & Technology (India) Limited stock ₹2,331, price ₹6,363, that is 63.4% below the price, quality 46 out of 100. Rating: strongly overvalued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials IN · ISIN INE473D01015

KS Kingfa Science & Technology (India) Limited logo Some data Nov 12, 2026

Kingfa Science & Technology (India) Limited

KINGFA · NSE

Far too expensive (fair value 63% below the price) and weak company, but rising price: meets 1 of 3 rules.

Get notified free when this changes
Rising price (uptrend) 
Solidly profitable · 10.2% net margin (TTM) 
Low debt 
Last quarter vs. a year ago: revenue +49%, profit +80%. 
Quality 46/100 
Expensive Growth (revenue 5y +26.0 %/yr in INR) 
Mixed vs. peers (6/12) 
Moderate moat 60/100 · thin data
Some data 
Fair value ₹2,331 · Strongly overvalued 
Negative free cash flow 
⟳ Cyclical⚠ Small free float
Watch Kingfa Science & Technology (India) Limited for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

₹6,933 ₹760.66 Fair Value ₹2,331 Jul 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 12, 2026.

How to read this chart

60‑month range ₹760.66 – ₹6,933 · fair‑value band ₹1,823 – ₹2,905 · the ₹6,363 price screens above the ₹2,331 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 12, 2026.

Follow Kingfa Science & Technology (India) in your weekly email

Every Wednesday you see whether Kingfa Science & Technology (India) is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Kingfa Science & Technology (India) Limited manufactures and supplies reinforced polypropylene compounds, thermoplastics elastomers, and personal protective equipment masks and gloves in India.

Show moreShow less

It also offers engineering plastics including ABS, HIPS, PA, PBT, PC and their alloys; biodegradable nitrile gloves and protective coverall; thermoplastic elastomers under the HYPRENE brand name; POM and LFT products; fiberglass honeycomb composite panels; polypropylene products; PA6/PA66 products; engineering plastics compounds; and high temperature resistant nylon/LCP. The company was formerly known as Hydro S&S Industries Limited and changed its name to Kingfa Science & Technology (India) Limited in March 2016.

The company was incorporated in 1983 and is based in Pune, India. Kingfa Science & Technology (India) Limited is a subsidiary of M/s Kingfa Science & Technology Co. Ltd China.

Stock analysis

Kingfa Science & Technology (India) Limited (KINGFA) currently trades at ₹6,363, while our model-based Fair Value estimate is ₹2,331, 63% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of ₹3,271 per share, and 0 of the 15 models we run sit above the ₹6,363 price.

Bear case: the Asset-Based group reads lowest at ₹754.11, and 15 of the 15 models stay below the price. Data coverage for this calculation is medium.

Scenario range: ₹1,823 (bear) to ₹2,905 (bull), the price of ₹6,363 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 46/100 (below-average quality), in the Basic Materials sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Kingfa Science & Technology (India) Limited reported revenue of ₹20.0B in FY2026 versus ₹10.5B in FY2022, a compound +17.5%/yr. Reported net income was ₹1.9B in FY2026, compounding +56.8%/yr from FY2022. FY2022 was a trough year, so the rate overstates the trend.

Key figures

Market cap ₹85.8B (≈ $911M) Small · P/E ratio 38.2 · P/S ratio 3.90 · EPS (TTM) ₹166.54 · Net margin 10.2% · Return on equity 17.4% · Return on assets (EBIT) 13.7% (5-year average) · Operating margin 15.8%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 60 out of 100 (low confidence).

What moves the price

The share trades about 8% below its 52-week high and 69% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −48% fair-value upside, at −63%, KINGFA screens richer than that median.

Fair Value models

Bear ₹1,823 Fair Value ₹2,331 Bull ₹2,905
Price ₹6,363 · Downside -63.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 8 months old). Earnings retained since then (₹104.94 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Residual Income ₹877.39 ₹985.38 ₹1,315 76
EPV ₹1,255 ₹1,367 ₹1,457 74
ROIC Compounder ₹1,359 ₹1,667 ₹2,000 72
All 16 models by family
Earnings-Based
Graham-Dodd ₹929.62 ₹6,135 ₹8,590 63
Lynch FV ₹1,790 ₹2,556 ₹3,323 61
PEG = 1.0 ₹1,790 ₹2,556 ₹3,323 57
EPV ₹1,255 ₹1,367 ₹1,457 74
Dividend Discount
Gordon GGM n/a ₹0.0100 ₹0.0100 67
DDM Multi-Stage n/a n/a ₹0.0100 63
Multiples
P/E Multiple ₹1,743 ₹2,324 ₹2,905 63
P/S Multiple ₹1,657 ₹2,209 ₹2,761 58
P/B Multiple ₹2,323 ₹3,098 ₹3,872 55
EV/EBIT ₹2,212 ₹2,850 ₹3,488 66
EV/EBITDA ₹1,823 ₹2,331 ₹2,838 67
EV/Revenue ₹1,845 ₹2,508 ₹3,171 54
Asset-Based
NCAV (Graham) ₹497.71 ₹754.11 ₹942.64 54
Economic Profit
Residual Income ₹877.39 ₹985.38 ₹1,315 76
ROIC Compounder ₹1,359 ₹1,667 ₹2,000 72
Growth Earnings
Growth-Adj P/E ₹2,290 ₹3,271 ₹4,253 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 46/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 58
How much profit the company makes from its sales and capital
Quality Growth 40
Are margins and returns getting better?
Cashflow 8
Do the profits arrive as real cash?
Financial strength 96
Debt, balance sheet and risk of trouble
Investment 27
Does it invest with discipline instead of growing at any price?
Low Volatility 67
How calm the share price moves, does not count
Price momentum 71
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 85
Distance to the 52-week high, does not count
New shares 41
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+14.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+26.0%
Start year 2021 (pandemic). Over 10 years: +20.3% a year
Revenue growth 20 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+17.4%
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+48.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+48.0%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.48.0% vs 27.7%, picking up
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.2% → 12%
Pace: the 5-year rate starts in 2021 (pandemic)

KINGFA screens overvalued: fair value 63% below the price. Compare with Linde plc →

Compare Kingfa Science & Technology (India) Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 755 stocks

Beats the industry median on 5/11 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 46 · Below median
Fair Value upside −63.7% · Bottom 25%
Profitability
Return on equity (12 months) 17.4% · Top 25%
Return on assets 10.6% · Top 25%
Net margin (12 months) 10.2% · Above median
Operating margin (12 months) 15.8% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) 49.1% · Top 25%

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/E (12 months) 38.2× · Priciest 25%
P/B 6.19× · Priciest 25%
P/S (12 months) 3.90× · Priciest 25%
EV/EBITDA 24.8× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 4
FUTURE (revenue growth)100 · sector 69
PAST (return on equity)70 · sector 26
HEALTH (low debt)100 · sector 95
DIVIDEND (yield)0 · sector 30

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Wanhua Chemical Group 600309 ¥68.09 ¥68.03 +0% vs KINGFA
Linde plc LIN $526.06 $446.62 −15% vs KINGFA
PPG Industries, Inc PPG $122.56 $77.68 −37% vs KINGFA
DSM-Firmenich AG DSFIR CHF 97.75 CHF 58.34 −40% vs KINGFA
Sika AG SIKA CHF 191.95 CHF 98.89 −48% vs KINGFA
The Sherwin-Williams Company SHW $349.89 $152.59 −56% vs KINGFA
Givaudan SA GIVN CHF 4,090 CHF 1,629 −60% vs KINGFA
EMS-CHEMIE HOLDING AG EMSN CHF 846.50 CHF 284.63 −66% vs KINGFA
Ecolab Inc ECL $309.27 $97.18 −69% vs KINGFA
Air Products and Chemicals, Inc APD $316.53 $75.33 −76% vs KINGFA

Explore undervalued stocks

More undervalued Basic Materials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Kingfa Science & Technology (India) Limited: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Kingfa Science & Technology (India) Limited Fair Value". https://www.fairvalue-calculator.com/stock/KINGFA

Frequently asked questions

Is Kingfa Science & Technology (India) Limited (KINGFA) overvalued or undervalued?
As of Nov 12, 2026, our model estimates a fair value of ₹2,331 versus a price of ₹6,363, about 63% lower (overvalued).
What is the fair value of KINGFA?
Our model-based fair value for Kingfa Science & Technology (India) Limited is ₹2,331 (as of Nov 12, 2026), built from audited fundamentals. The current price: ₹6,363.
What is the quality score of KINGFA?
Kingfa Science & Technology (India) Limited has a Quality Score of 46/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Kingfa Science & Technology (India) Limited (KINGFA)?
Our model-based price target is the fair value of ₹2,331 (as of Nov 12, 2026) from 16 valuation models. Cautious scenario ₹1,823, optimistic scenario ₹2,905. It is a calculation from audited fundamentals, not an analyst target.
What is the Kingfa Science & Technology (India) Limited stock forecast for 2026?
Our models put fair value at ₹2,331, about 63% lower versus a price of ₹6,363 (overvalued). Cautious scenario ₹1,823, optimistic scenario ₹2,905. The calculation is refreshed regularly with new filings.
What is the revenue of Kingfa Science & Technology (India) Limited (KINGFA)?
Kingfa Science & Technology (India) Limited reported trailing-twelve-month revenue of about ₹22.2B (latest available figure, as of Nov 12, 2026).
What is the intrinsic value of Kingfa Science & Technology (India) Limited (KINGFA)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Kingfa Science & Technology (India) Limited it is ₹2,331 per share (as of Nov 12, 2026), against a price of ₹6,363. It is the blended result of 16 valuation models in 6 families (Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Kingfa Science & Technology (India) Limited stock overvalued or undervalued in 2026?
As of Nov 12, 2026, KINGFA trades above its calculated fair value: price ₹6,363, fair value ₹2,331, a gap of about −63% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of KINGFA?
No. The price is what the market pays today (₹6,363); the fair value is what the company's own numbers justify (₹2,331). For Kingfa Science & Technology (India) Limited the two are ₹4,032 per share apart. That gap is exactly why we show both numbers side by side.
How much is Kingfa Science & Technology (India) Limited worth?
The market values Kingfa Science & Technology (India) Limited at about ₹85.8B (market capitalisation, as of Nov 12, 2026). Per share that is ₹6,363; our models calculate a fair value of ₹2,331 per share.
What do the bullish and bearish scenarios say about KINGFA?
Our models span a range for Kingfa Science & Technology (India) Limited: cautious scenario ₹1,823, base ₹2,331, optimistic ₹2,905 per share (as of Nov 12, 2026, price ₹6,363). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of KINGFA?
Kingfa Science & Technology (India) Limited trades at a price-to-earnings ratio of 38.2 (as of Nov 12, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹2,331 is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2017 to 2026), reported earnings: 35.6. Other multiples: P/B 6.2, P/S 3.9, EV/EBITDA 24.8.
How solid is the balance sheet of Kingfa Science & Technology (India) Limited (KINGFA)?
Balance-sheet figures for Kingfa Science & Technology (India) Limited (as of Nov 12, 2026): return on equity 17.4%. They feed the Quality Score of 46/100, which measures business quality independently of the share price.
How far is KINGFA from its 52-week high?
Kingfa Science & Technology (India) Limited trades at ₹6,363, about 8% below its 52-week high of ₹6,933 and 69% above the low of ₹3,759 (as of Nov 16, 2026). Distance from the high says nothing about value: that is what the fair value of ₹2,331 is for.
Which stocks are comparable to Kingfa Science & Technology (India) Limited?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Kingfa Science & Technology (India) Limited stock attractive at the current price?
The data as of Nov 12, 2026: price ₹6,363, calculated fair value ₹2,331 (−63%), Quality Score 46/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of KINGFA calculated?
We run Kingfa Science & Technology (India) Limited through 16 models from 6 families: Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ₹2,331 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5% above its aggregate fair value. Kingfa Science & Technology (India) Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Kingfa Science & Technology (India) Limited (KINGFA)?
The closing price on Nov 16, 2026 was ₹6,363. Our model-based fair value is ₹2,331, about 63% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Kingfa Science & Technology (India) Limited right now?
The price sits above even our optimistic bull case (₹2,905). The favourable scenario is already priced in. Weak quality (46/100) and above fair value at the same time, the margin of safety is missing on both counts.
Where does the earnings growth of Kingfa Science & Technology (India) Limited (KINGFA) come from?
Earnings per share at Kingfa Science & Technology (India) Limited grew 31.2 % a year from 2016 to 2026. Broken into its drivers: revenue per share +15.8 %, EBIT margin +11.6 %, tax rate +1.4 %, residual (interest, one-offs) +0.1 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Kingfa Science & Technology (India) Limited

How large is the market capitalisation of Kingfa Science & Technology (India) Limited (KINGFA)?
The market capitalisation of Kingfa Science & Technology (India) Limited is ₹85.8B (≈ $911M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Kingfa Science & Technology (India) Limited (KINGFA)?
The price-to-sales ratio of Kingfa Science & Technology (India) Limited is 3.90 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Kingfa Science & Technology (India) Limited (KINGFA)?
Earnings per share at Kingfa Science & Technology (India) Limited are ₹166.54 (price ÷ EPS = P/E 38.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Kingfa Science & Technology (India) Limited (KINGFA)?
The net margin of Kingfa Science & Technology (India) Limited is 10.2% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Kingfa Science & Technology (India) Limited (KINGFA)?
The return on equity (ROE) of Kingfa Science & Technology (India) Limited is 17.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Kingfa Science & Technology (India) Limited (KINGFA)?
On an EBIT basis the return on assets of Kingfa Science & Technology (India) Limited is 13.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Kingfa Science & Technology (India) Limited (KINGFA)?
The operating margin of Kingfa Science & Technology (India) Limited is 15.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Kingfa Science & Technology (India) Limited (KINGFA)?
Revenue at Kingfa Science & Technology (India) Limited is growing 49.1% versus a year earlier (3y avg +12.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Kingfa Science & Technology (India) Limited (KINGFA)?
Earnings per share at Kingfa Science & Technology (India) Limited are growing 80.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Kingfa Science & Technology (India) Limited (KINGFA) generate?
The free cash flow of Kingfa Science & Technology (India) Limited is −₹436M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Kingfa Science & Technology (India) Limited (KINGFA) hold?
Kingfa Science & Technology (India) Limited holds more cash than debt, ₹4.1B net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Kingfa Science & Technology (India) Limited in the live analysis

One click puts Kingfa Science & Technology (India) Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.